Company news
Nexien BioPharma, Inc. news in 2018
Nexien BioPharma, Inc.'s news releases, calls and decks from 2018, newest first.
Nexien BioPharma Releases Letter to Shareholders Announcing 2019 Plans, 2018 Activities, and Work to Come From Acquisitions
December 6, 2018
Nexien BioPharma And Ivy League University Medical School Collaborate On Pre-Clinical Cannabinoid Studies
November 28, 2018
Uptick Newswire's Stock Day Podcast Interviews Nexien BioPharma CEO, Alex Wasyl, to Discuss the Acquisition of CRX Bio Holdings and The Company’s Future in The Pharmaceutical Space
November 25, 2018
Nexien BioPharma Advances in Clinical Use of a Cannabinoid-Based Formulation for the Treatment of Myotonic Dystrophies and Myotonia
November 5, 2018
Nexien BioPharma Acquires Princeton-Based CRx Bio and Announces Additions to Senior Management
October 29, 2018
INTIVA BioPharma Inc. Announces Name Change to Nexien BioPharma Inc.
September 30, 2018
INTIVA BioPharma (OTCQB: NTVA) Files a Listing Application with the Canadian Securities Exchange (CSE)
August 21, 2018
INTIVA BioPharma Inc (NTVA) Begins Trading on the OTCQB Venture Market
July 18, 2018
INTIVA BioPharma Retains Dr. Benedikt Schoser as an Advisor
July 11, 2018